A detailed history of Verus Capital Partners, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Verus Capital Partners, LLC holds 20,049 shares of PFE stock, worth $535,709. This represents 0.05% of its overall portfolio holdings.

Number of Shares
20,049
Previous 21,184 5.36%
Holding current value
$535,709
Previous $592,000 2.03%
% of portfolio
0.05%
Previous 0.06%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

SELL
$27.7 - $31.39 $31,439 - $35,627
-1,135 Reduced 5.36%
20,049 $580,000
Q2 2024

Aug 01, 2024

BUY
$25.26 - $29.6 $130,467 - $152,884
5,165 Added 32.24%
21,184 $592,000
Q1 2024

May 07, 2024

BUY
$25.89 - $29.73 $2,744 - $3,151
106 Added 0.67%
16,019 $444,000
Q4 2023

Feb 09, 2024

BUY
$26.13 - $33.94 $35,876 - $46,599
1,373 Added 9.44%
15,913 $458,000
Q3 2023

Nov 01, 2023

SELL
$32.09 - $37.51 $69,667 - $81,434
-2,171 Reduced 12.99%
14,540 $482,000
Q2 2023

Jul 31, 2023

BUY
$36.12 - $41.79 $50,134 - $58,004
1,388 Added 9.06%
16,711 $612,000
Q1 2023

May 09, 2023

SELL
$39.39 - $51.28 $37,814 - $49,228
-960 Reduced 5.9%
15,323 $625,000
Q4 2022

Feb 14, 2023

SELL
$41.75 - $54.5 $21,877 - $28,558
-524 Reduced 3.12%
16,283 $834,000
Q3 2022

Nov 14, 2022

BUY
$43.76 - $53.42 $268,117 - $327,304
6,127 Added 57.37%
16,807 $736,000
Q2 2022

Aug 09, 2022

SELL
$46.53 - $55.17 $359,118 - $425,802
-7,718 Reduced 41.95%
10,680 $920,000
Q1 2022

Aug 09, 2022

SELL
$45.75 - $56.69 $45,475 - $56,349
-994 Reduced 5.13%
18,398 $912,000
Q1 2020

May 26, 2020

BUY
$27.03 - $38.62 $32,679 - $46,691
1,209 Added 6.65%
19,392 $633,000
Q4 2019

Feb 27, 2020

BUY
$32.92 - $37.36 $598,584 - $679,316
18,183 New
18,183 $712,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $150B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Verus Capital Partners, LLC Portfolio

Follow Verus Capital Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Verus Capital Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Verus Capital Partners, LLC with notifications on news.